Reducing BMI below the obesity threshold in adolescents treated with once-weekly subcutaneous semaglutide 2.4 mg: A post-hoc analysis from the STEP TEENS randomised controlled trial

Speaker

Dr. Michael A. Tsoukas, MD, FRCPC

Dr Michael Tsoukas is an Associate Professor of Medicine, Division of Endocrinology of the McGill University Health Centre and Research Investigator of the Research Institute of McGill and Hygea Medical Clinic. He completed his residency in internal medicine at Tuft’s University in Boston and subsequently trained in Endocrinology at McGill University. Upon completion, he pursued a postgraduate research fellowship in diabetes and obesity at Harvard University (Beth Israel Deaconess Medical Center), with a focus on GLP-1 receptor pharmacotherapy, brain signaling, and enterohormone treatments. Special interests include pathophysiological regulation of molecules such as SGLT-2 inhibitors and GLP-1 receptor agonists important in energy homeostasis, diabetes, and obesity.